Harvard Bioscience announced the appointment of Jennifer Cote as the Company’s Chief Financial Officer and Treasurer, effective June 19, 2023. Cote joined the Company as Vice President of Global Finance in May 2022 and has served as Interim Chief Financial Officer and Treasurer since January 2023.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on HBIO:
- Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
- Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023
- Harvard Bioscience price target raised to $7 from $4 at Benchmark
- Harvard Bioscience Announces First Quarter 2023 Financial Results
- Harvard Bioscience reports Q1 adjusted EPS 6c, consensus 5c